ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,905
0,44%
Bitcoin
57 319,23
-1,58%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Charles River Laboratories International Inc (CRL)

  7. Charles River Laboratories International Inc (CRL) Actualités

CRL Charles River Laboratories International Inc

232,69
3,69 (1,61%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Charles River Laboratories International Inc CRL NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
3,69 1,61% 232,69 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
229,80 226,44 237,62 232,69 229,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202414:00BWCharles River Laboratories Achieves 100% Renewable..
16/4/202414:00BWCharles River Laboratories Launches Alternative Methods..
12/4/202414:00BWCharles River Laboratories Schedules First-Quarter 2024..
11/4/202414:00BWCharles River and Deciphex Launch Patholytix Foresight, a..
09/4/202414:00BWCharles River Announces Rare Disease Gene Therapy..
04/4/202414:00BWCharles River to Perform Plasmid Production for Ship of..
01/4/202414:00BWCharles River Laboratories Showcases Technology-Driven..
27/3/202413:00BWCharles River Laboratories Publishes 2023 Corporate..
21/3/202413:00BWCharles River Announces Extension of Gene Therapy..
14/3/202413:00BWCharles River and Navega Therapeutics Announce Comprehensive..
12/3/202413:00BWCharles River Laboratories to Present at Barclays Global..
11/3/202421:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202420:34EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:47EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202421:14EDGAR2Form 144 - Report of proposed sale of securities
29/2/202418:42EDGAR2Form 144 - Report of proposed sale of securities
29/2/202408:00PRNUSWheeler Bio Seals Agreement with Charles River to Offer..
23/2/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:09EDGAR2Form 144 - Report of proposed sale of securities
21/2/202414:00BWCharles River and Wheeler Bio Complete Agreement to..
20/2/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:08BWCharles River Collaborates with Pluristyx, Expanding its..
17/2/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:04EDGAR2Form 144 - Report of proposed sale of securities
15/2/202417:02EDGAR2Form 144 - Report of proposed sale of securities
14/2/202413:30EDGAR2Form 8-K - Current report
14/2/202413:00BWCharles River Laboratories Announces Fourth Quarter and..
06/2/202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:34EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
31/1/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202414:00BWCharles River Introduces the First Rapid Animal-Free..
24/1/202422:34EDGAR2Form 8-K - Current report
24/1/202422:30BWCharles River Laboratories Adds Reshema Kemps-Polanco to..
23/1/202422:30BWCharles River Laboratories Schedules Fourth-Quarter 2023..
16/1/202422:32EDGAR2Form 8-K - Current report
16/1/202414:00BWCharles River Launches Rep/Cap Plasmids to Streamline..
11/1/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:00BWCharles River Laboratories to Present at J.P. Morgan..

Dernières Valeurs Consultées

NYSE
CRL
Charles River Laboratories
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés